Breaking News Instant updates and real-time market news.

COF

Capital One

$97.95

1.93 (2.01%)

, KBR

KBR

$18.43

0.22 (1.21%)

10:05
06/14/18
06/14
10:05
06/14/18
10:05

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Capital One (COF) upgraded to Overweight from Neutral at Piper Jaffray with analyst Kevin Barker saying the company's credit profile has improved faster than expected. 2. KBR (KBR) upgraded to Neutral from Sell at Goldman Sachs. 3. NL Industries (NL) upgraded to Equal Weight from Underweight at Barclays with analyst Duffy Fischer saying improvement in equity earnings at Kronos, primarily due to higher TiO2 price realization, provides a better outlook. 4. W&T Offshore (WTI) upgraded to Buy from N/A previously at Seaport Global with analyst Mike Kelly citing an improved oil price outlook, industry-wide capital improvements across the Gulf of Mexico, and company specific events including the attractively priced acquisition and a transformational JV agreement. 5. American Campus (ACC) upgraded to Buy from Neutral at BofA/Merrill with analyst Juan Sanabria saying American Campus is positioning to be a leader in student housing and sees support from institutional interest in the space and views it as attractive versus multifamily valuations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

COF

Capital One

$97.95

1.93 (2.01%)

KBR

KBR

$18.43

0.22 (1.21%)

NL

NL Industries

$9.80

0.15 (1.55%)

WTI

W&T Offshore

$6.74

0.3 (4.66%)

ACC

American Campus

$43.23

0.355 (0.83%)

  • 14

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 24

    Jul

COF Capital One
$97.95

1.93 (2.01%)

06/14/18
PIPR
06/14/18
UPGRADE
Target $116
PIPR
Overweight
Capital One upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Kevin Barker upgraded Capital One Financial to Overweight and raised his price target for the shares to $116 from $98. The company's credit profile has improved faster than expected, Barker tells investors in a research note. He increased his estimates for Capital One and believes consensus expectations are not adequately reflecting improved credit trends and higher net interest margin from mortgage sales.
04/25/18
BMOC
04/25/18
NO CHANGE
Target $133
BMOC
Outperform
Capital One price target lowered to $133 from $140 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Capital One to $133 after the company's Q1 results, saying that despite the earnings beat, "higher expected taxes and fewer buybacks offset lower expected provisions" for loan loss. The analyst keeps his Outperform rating however, noting the stock price has some upside based on its discount valuation relative to regional banks as the company remains his "highest-conviction long-term investment recommendation" in the space.
04/05/18
04/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Buy at Canaccord and Stifel. 2. Trade Desk (TTD) initiated with an Overweight at Piper Jaffray. 3. Saul Centers (BFS) initiated with a Neutral at B. Riley FBR. 4. Capital One (COF) and American Express (AXP) were initiated with a Buy at Citi while Discover (DFS) and Synchrony (SYF) were initiated with a Neutral. 5. Intel (INTC) initiated with a Buy at UBS while Qualcomm (QCOM) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/18
BMOC
05/09/18
NO CHANGE
Target $126
BMOC
Outperform
Capital One price target lowered to $126 from $133 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Capital One to $126, modeling lower net interest income from reduced loan balances that "more than offsets" higher stock repurchases after yesterday's announced sale of $17B in mortgage loans. The analyst also keeps his Outperform rating, adding that he sees upside for Capital One valuation multiple and positive indirect effects from the Tax Cuts and Jobs Act.
KBR KBR
$18.43

0.22 (1.21%)

04/27/18
DADA
04/27/18
UPGRADE
Target $21
DADA
Buy
KBR upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Brent Thielman upgraded KBR to Buy from Neutral and raised his price target to $21 from $17.50 after its Q1 earnings beat. Thielman says that the company's results suggest that the Hydrocarbon Services bookings imply a rebound for Q2, while the "troubled" Ichthys project is on target. The analyst also expects the less risky Government Services and Technology business to represent 86% of backlog in 2019 adding to the earnings momentum.
02/26/18
FBCO
02/26/18
DOWNGRADE
Target $16
FBCO
Neutral
KBR downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Jamie Cook downgraded KBR to Neutral from Outperform as he believes the Ichthys problem project coupled with what is now a highly levered balance sheet and potential risk of a modest equity raise will be an overhang on the stock. The analyst also lowered his price target on the shares to $16 from $24.
06/14/18
GSCO
06/14/18
NO CHANGE
GSCO
Goldman upgrades KBR to Neutral, downgrades Terex to Sell
Goldman Sachs analyst Jerry Revich last night upgraded KBR (KBR) to Neutral from Sell and raised his price target for the shares to $19 from $14. The analyst also downgraded Terex to Sell from Neutral and lowered his price target for the shares to $34 from $43. On KBR, Revich sees the company benefiting from a significant liquefied natural gas sanctioning cycle. He believes this thesis of earnings challenges from legacy LNG projects rolling off and portfolio de-risking has largely played out. On Terex, the analyst expects rental industry capacity additions of its core products to hit a peak this year. Revich also upgraded his view on the U.S. Engineering and Construction sector to Attractive on expectations an organic growth inflection will be seen in Q2 for the first time in five years.
06/13/18
GSCO
06/13/18
UPGRADE
GSCO
Neutral
KBR upgraded to Neutral from Sell at Goldman Sachs
NL NL Industries
$9.80

0.15 (1.55%)

06/14/18
LEHM
06/14/18
UPGRADE
Target $16
LEHM
Equal Weight
NL Industries upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Duffy Fischer upgraded NL Industries to Equal Weight and raised his price target for the shares to $16 from $14.
06/14/18
LEHM
06/14/18
UPGRADE
Target $16
LEHM
Equal Weight
NL Industries upgraded to Equal Weight with $16 target at Barclays
Barclays analyst Duffy Fischer upgraded NL Industries to Equal Weight from Underweight and raised his price target for the shares to $16 from $14. Improvement in equity earnings at Kronos, primarily due to higher TiO2 price realization, provides a better outlook, Fischer tells investors in a research note. He points out, however, that the stock "still carries significant risk" from volatility, low liquidity and legal/environmental liability.
WTI W&T Offshore
$6.74

0.3 (4.66%)

06/14/18
GHSC
06/14/18
UPGRADE
GHSC
Buy
W&T Offshore upgraded to Buy from N/A previously at Seaport Global
Seaport Global analyst Mike Kelly upgraded W&T Offshore to Buy from N/A previously with a $9 price target citing an improved oil price outlook, industry-wide capital improvements across the Gulf of Mexico, and company specific events including the attractively priced acquisition and a transformational JV agreement. Kelly said W&T's Gulf of Mexico assets have been revitalized and leverage "drastically" improved.
05/23/18
05/23/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Quantenna Communications (QTNA) initiated with a Buy at Stifel. 2. Cesca Therapeutics (KOOL) initiated with a Buy at H.C. Wainwright. 3. W&T Offshore (WTI) initiated with a Neutral at Roth Capital. 4. Carrols Restaurant (TAST) initiated with a Buy at SunTrust. 5. Vanda initiated with a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/23/18
ROTH
05/23/18
INITIATION
Target $8.75
ROTH
Neutral
W&T Offshore initiated with a Neutral at Roth Capital
Roth Capital analyst John White initiated W&T Offshore with a Neutral rating and $8.75 price target, citing his view that the shares are fully valued at current levels.
05/16/18
SOCO
05/16/18
DOWNGRADE
SOCO
Underweight
W&T Offshore downgraded to Underweight from Equalweight at Capital One
Capital One analyst Richard Tullis downgraded W&T Offshore to Underweight from Equalweight.
ACC American Campus
$43.23

0.355 (0.83%)

02/22/18
HDLY
02/22/18
UPGRADE
Target $41
HDLY
Long-Term Buy
American Campus upgraded to Long-Term Buy from Neutral at Hilliard Lyons
Hilliard Lyons analyst Carol Kemple upgraded American Campus Communities to Long-Term Buy with a two year price target of $41. The analyst says she feels better about the near-term and long-term outlook of the company following the Q4 results. She notes the stock, like most real estate investment trusts, have pulled back recently.
06/14/18
BOFA
06/14/18
UPGRADE
BOFA
Buy
American Campus upgraded to Buy from Neutral at BofA/Merrill
06/14/18
BOFA
06/14/18
UPGRADE
BOFA
Buy
American Campus upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill upgraded American Campus (ACC) to Buy from Neutral and raised its price target to $46.50 from $43. Analyst Juan Sanabria said American Campus is positioning to be a leader in student housing and sees support from institutional interest in the space and views it as attractive versus multifamily valuations. The analyst said better than expected recent asset sale prices and reports of the EdR (EDR) privatization bid support his higher price target.
01/12/18
SDLR
01/12/18
UPGRADE
Target $45
SDLR
Buy
American Campus upgraded to Buy from Hold at Sandler O'Neill
Sandler O'Neill analyst Alexander Goldfarb upgraded American Campus Communities to Buy with a $45 price target. The analyst believes management is "determined to deliver stronger for the upcoming preleasing season."

TODAY'S FREE FLY STORIES

SEAS

SeaWorld

$29.91

-0.19 (-0.63%)

15:35
09/24/18
09/24
15:35
09/24/18
15:35
Options
SeaWorld put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$95.05

-0.8 (-0.83%)

, IBM

IBM

$149.98

-1.31 (-0.87%)

15:31
09/24/18
09/24
15:31
09/24/18
15:31
Periodicals
Walmart requires lettuce, spinach suppliers to join blockchain, WSJ reports »

In a letter to suppliers,…

WMT

Walmart

$95.05

-0.8 (-0.83%)

IBM

IBM

$149.98

-1.31 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

FL

Foot Locker

$47.57

-0.71 (-1.47%)

15:25
09/24/18
09/24
15:25
09/24/18
15:25
Options
Foot Locker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

CDNA

CareDx

$26.73

0.75 (2.89%)

, NTRA

Natera

$23.95

-0.23 (-0.95%)

15:25
09/24/18
09/24
15:25
09/24/18
15:25
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts discuss…

CDNA

CareDx

$26.73

0.75 (2.89%)

NTRA

Natera

$23.95

-0.23 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 01

    Oct

  • 15

    Nov

  • 27

    Nov

SBUX

Starbucks

$56.91

-0.49 (-0.85%)

15:24
09/24/18
09/24
15:24
09/24/18
15:24
Periodicals
Starbucks plans 'significant changes' to company structure, Bloomberg says »

Starbucks is planning an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TMK

Torchmark

$88.45

-0.51 (-0.57%)

15:17
09/24/18
09/24
15:17
09/24/18
15:17
Syndicate
Breaking Syndicate news story on Torchmark »

Torchmark files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/24/18
09/24
15:17
09/24/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/24/18
09/24
15:16
09/24/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$95.09

-0.76 (-0.79%)

15:10
09/24/18
09/24
15:10
09/24/18
15:10
Periodicals
Walmart requires lettuce, spinach suppliers to join blockchain, WSJ reports »

In a letter to suppliers,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

WFC

Wells Fargo

$54.35

-0.6 (-1.09%)

15:10
09/24/18
09/24
15:10
09/24/18
15:10
Options
Wells Fargo with a notable option spread as shares slip »

Wells Fargo with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

BSX

Boston Scientific

$38.37

0.61 (1.62%)

15:05
09/24/18
09/24
15:05
09/24/18
15:05
Options
Boston Scientific call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 09

    Oct

SWCH

Switch

$10.83

-0.23 (-2.08%)

, INTC

Intel

$46.92

0.28 (0.60%)

15:04
09/24/18
09/24
15:04
09/24/18
15:04
Hot Stocks
Intel Capital sells about 1.728M shares of Switch »

According to a regulatory…

SWCH

Switch

$10.83

-0.23 (-2.08%)

INTC

Intel

$46.92

0.28 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 22

    Oct

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

, AMRN

Amarin

$11.62

8.62 (287.33%)

15:03
09/24/18
09/24
15:03
09/24/18
15:03
Recommendations
Matinas BioPharma, Amarin analyst commentary  »

Amarin's Vascepa…

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

AMRN

Amarin

$11.62

8.62 (287.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

15:00
09/24/18
09/24
15:00
09/24/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KOS

Kosmos

$9.45

-0.06 (-0.63%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Hot Stocks
Breaking Hot Stocks news story on Kosmos »

First Reserve GP XIII…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.76

-0.3 (-2.71%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CGC

Canopy Growth

$52.68

2.92 (5.87%)

, CVSI

CV Sciences

$0.00

(0.00%)

14:55
09/24/18
09/24
14:55
09/24/18
14:55
Hot Stocks
NY Governor signs bill adding pain management as condition for medical marijuana »

New York Governor Andrew…

CGC

Canopy Growth

$52.68

2.92 (5.87%)

CVSI

CV Sciences

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CRON

Cronos Group

$11.80

-0.71 (-5.68%)

TLRY

Tilray

$105.00

-18.155 (-14.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

SBUX

Starbucks

$56.88

-0.52 (-0.91%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Periodicals
Starbucks plans 'significant changes' to company structure, Bloomberg says »

Starbucks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

RRGB

Red Robin

$38.65

-0.55 (-1.40%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Conference/Events
Red Robin management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ASNA

Ascena Retail

$3.94

-0.29 (-6.86%)

14:49
09/24/18
09/24
14:49
09/24/18
14:49
Options
Ascena Retail options imply 24.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AMRN

Amarin

$11.13

8.13 (271.00%)

, SNY

Sanofi

$43.33

-0.28 (-0.64%)

14:48
09/24/18
09/24
14:48
09/24/18
14:48
Hot Stocks
Amarin CEO says Vascepa 'more analogous' to statins than PCSK9 inhibitors »

Amarin CEO John Thero…

AMRN

Amarin

$11.13

8.13 (271.00%)

SNY

Sanofi

$43.33

-0.28 (-0.64%)

REGN

Regeneron

$388.88

-1.67 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 20

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

TRXC

TransEnterix

$6.70

0.27 (4.20%)

14:45
09/24/18
09/24
14:45
09/24/18
14:45
Options
TransEnterix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

SPPI

Spectrum

$17.18

-4.19 (-19.61%)

14:44
09/24/18
09/24
14:44
09/24/18
14:44
Hot Stocks
Spectrum drops over 20% after releasing poziotinib data from Phase 2 study »

Shares of Spectrum are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

JNJ

Johnson & Johnson

$140.67

-2.18 (-1.53%)

14:43
09/24/18
09/24
14:43
09/24/18
14:43
Periodicals
J&J talc cancer case in California ends in mistrial, Bloomberg reports »

Johnson &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

VSTM

Verastem

$8.98

0.31 (3.58%)

14:39
09/24/18
09/24
14:39
09/24/18
14:39
Hot Stocks
Verastem's Duvelisib approved by FDA »

Duvelisib capsules for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.